Coexistence of a JAK2 Mutated Clone May Cause Hematologic Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E41
DOI: 10.3816/clm.2009.n.102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Carmen Fava und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fava, C., Cambrin, G. R., Ferrero, D., Ulisciani, S., & Serra, A. (2009). Coexistence of a JAK2 Mutated Clone May Cause Hematologic Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Clinical Lymphoma and Myeloma, 9(6), E41. https://doi.org/10.3816/clm.2009.n.102
Vancouver
Fava C, Cambrin GR, Ferrero D, Ulisciani S, Serra A. Coexistence of a JAK2 Mutated Clone May Cause Hematologic Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Clinical Lymphoma and Myeloma. 2009;9(6):E41. doi:10.3816/clm.2009.n.102
BibTeX
@article{Fava2009,
author = {Fava, Carmen and Cambrin, Giovanna Rege and Ferrero, Dario and Ulisciani, Stefano and Serra, Anna},
title = {Coexistence of a JAK2 Mutated Clone May Cause Hematologic Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia},
journal = {Clinical Lymphoma and Myeloma},
year = {2009},
volume = {9},
number = {6},
pages = {E41},
doi = {10.3816/clm.2009.n.102}
}
EUVIMED